Will The Crashing Copaxone Franchise Spell Doom For Teva Pharmaceutical? – Seeking Alpha


Seeking Alpha
Will The Crashing Copaxone Franchise Spell Doom For Teva Pharmaceutical?
Seeking Alpha
Teva Pharmaceutical can safeguard Copaxone franchise from generic competition even if it can uphold one of the two remaining patents. The judgement of the District Court of Wilmington, Delaware; expected in early 2017, may differ from that of the USĀ …

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd